Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major

被引:89
作者
Coelho, AC
Beverley, SM
Cotrim, PC
机构
[1] Univ Sao Paulo, Sch Med, Inst Trop Med, BR-05403900 Sao Paulo, Brazil
[2] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
关键词
Leishmania major; pentamidine; drug resistance; gene transfection; overexpression; P-glycoprotein;
D O I
10.1016/S0166-6851(03)00162-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pentamidine (PEN) is a second-line agent in the treatment of leishmaniasis whose mode of action and resistance is not well understood. Here, we used a genetic strategy to search for loci able to mediate PEN resistance (PENr) when overexpressed in Leishmania major. A shuttle cosmid library containing genomic DNA inserts was transfected into wild-type promastigotes and screened for PEN-resistant transfectants. Two different cosmids identifying the same locus were found, which differed from other known Leishmania drug resistance genes. The PENr gene was mapped by deletion and transposon mutagenesis to an open reading frame (ORF) belonging to the P-glycoprotein (PGP)/MRP ATP-binding cassette (ABC) transporter superfamily that we named pentamidine resistance protein 1 (PRP1). The predicted PRP1 protein encodes 1807 amino acids with the typical dimeric structure involving 10 transmembrane domains and two nucleotide-binding domains (NBDs). PRP1-mediated PENr could be reversed by verapamil and PRP1 overexpressors showed cross-resistance to trivalent antimony but not to pentavalent antimony (glucantime). Although the degree of PENr was modest (1.7- to 3.7-fold), this may be significant in clinical drug resistance given the marginal efficacy of PEN against Leishmania. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 38 条
[1]   A survey of the Leishmania major Friedlin strain V1 genome by shotgun sequencing:: a resource for DNA microarrays and expression profiling [J].
Akopyants, NS ;
Clifton, SW ;
Martin, J ;
Pape, D ;
Wylie, T ;
Li, L ;
Kissinger, JC ;
Roos, DS ;
Beverley, SM .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2001, 113 (02) :337-340
[2]   Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion [J].
Basselin, M ;
Denise, H ;
Coombs, GH ;
Barrett, MP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) :3731-3738
[3]   Modification of kinetoplast DNA minicircle composition in pentamidine-resistant Leishmania [J].
Basselin, M ;
Badet-Denisot, MA ;
Robert-Gero, M .
ACTA TROPICA, 1998, 70 (01) :43-61
[4]   GENE AMPLIFICATION IN LEISHMANIA [J].
BEVERLEY, SM .
ANNUAL REVIEW OF MICROBIOLOGY, 1991, 45 :417-444
[5]  
BORST P, 1995, ANNU REV MICROBIOL, V49, P427, DOI 10.1146/annurev.mi.49.100195.002235
[6]  
CALLAHAN HL, 1991, J BIOL CHEM, V266, P18427
[7]  
CALLAHAN HL, 1992, J BIOL CHEM, V267, P24165
[8]  
CARTER NS, 1995, J BIOL CHEM, V270, P28153, DOI 10.1074/jbc.270.47.28153
[9]   Altered drug membrane permeability in a multidrug resistant Leishmania tropica line [J].
Chiquero, MJ ;
PerezVictoria, J ;
OValle, F ;
GonzalezRos, JM ;
delMoral, RG ;
Ferragut, JA ;
Castanys, S ;
Gamarro, F .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (02) :131-139
[10]   CLONING AND FUNCTIONAL-ANALYSIS OF AN EXTRACHROMOSOMALLY AMPLIFIED MULTIDRUG RESISTANCE-LIKE GENE IN LEISHMANIA-ENRIETTII [J].
CHOW, LMC ;
WONG, AKC ;
ULLMAN, B ;
WIRTH, DF .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1993, 60 (02) :195-208